David Toapanta

3.3k total citations
17 papers, 134 citations indexed

About

David Toapanta is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Toapanta has authored 17 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in David Toapanta's work include Liver Disease and Transplantation (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Organ Transplantation Techniques and Outcomes (3 papers). David Toapanta is often cited by papers focused on Liver Disease and Transplantation (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Organ Transplantation Techniques and Outcomes (3 papers). David Toapanta collaborates with scholars based in Spain, United Kingdom and United States. David Toapanta's co-authors include Javier Fernández, Vicente Arroyo, Ingrid W. Zhang, María Hernández‐Tejero, Anna Curto, Juan José Lozano, Roger Flores‐Costa, Marta Duran‐Güell, Ferrán Aguilar and Mireia Casulleras and has published in prestigious journals such as Journal of Hepatology, Clinical Microbiology and Infection and Seminars in Liver Disease.

In The Last Decade

David Toapanta

13 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Toapanta Spain	6	66	65	36	30	27	17	134
Ane Zamalloa United Kingdom	7	96 1.5×	73 1.1×	32 0.9×	19 0.6×	23 0.9×	21	162
Haotang Ren China	5	67 1.0×	46 0.7×	34 0.9×	14 0.5×	19 0.7×	10	138
Alisa Likhitsup United States	9	158 2.4×	132 2.0×	29 0.8×	15 0.5×	43 1.6×	32	252
Larisa Vasilieva Greece	10	148 2.2×	143 2.2×	34 0.9×	28 0.9×	29 1.1×	20	239
Laura Weichselbaum Belgium	7	139 2.1×	98 1.5×	52 1.4×	21 0.7×	42 1.6×	11	265
Rocío Moreu Spain	7	182 2.8×	131 2.0×	39 1.1×	41 1.4×	52 1.9×	8	276
Dominic Dell Olio Italy	9	122 1.8×	177 2.7×	22 0.6×	45 1.5×	107 4.0×	18	312
Robert Mitrani United States	6	151 2.3×	140 2.2×	56 1.6×	12 0.4×	40 1.5×	9	228

Countries citing papers authored by David Toapanta

Since Specialization

Citations

This map shows the geographic impact of David Toapanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Toapanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Toapanta more than expected).

Fields of papers citing papers by David Toapanta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Toapanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Toapanta. The network helps show where David Toapanta may publish in the future.

Co-authorship network of co-authors of David Toapanta

This figure shows the co-authorship network connecting the top 25 collaborators of David Toapanta. A scholar is included among the top collaborators of David Toapanta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Toapanta. David Toapanta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Azancot, María, et al.. (2025). Long-Term Impact of Peritoneal Dialysis Ultrafiltration on Cardiorenal Patients. Cardiorenal Medicine. 15(1). 560–571.

Piñeiro, Gastón, Oswaldo Ortíz, Miquel Lozano, et al.. (2025). Bilirubin Removal with Therapeutic Plasma Exchange or Molecular Adsorbent Recirculating System as Treatment for Cholemic Nephropathy in Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Case Series. Blood Purification. 54(3). 160–166.

Azancot, María, et al.. (2025). A New Era in the Management of Cardiorenal Syndrome: The Importance of Cardiorenal Units.. Cardiorenal Medicine. 15(1). 1–20.

Meersseman, Philippe, María Hernández‐Tejero, Juan Manuel Díaz, et al.. (2025). Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial. Liver International. 45(9). e70257–e70257. 1 indexed citations

Cardoso, Filipe S., David Toapanta, António Figueiredo, et al.. (2024). Ammonia and urea metabolism in acute liver failure: A multicentre cohort study. Liver International. 44(10). 2651–2659. 1 indexed citations

Fernández, Javier, Octavi Bassegoda, David Toapanta, & William Bernal. (2024). Acute liver failure: A practical update. JHEP Reports. 6(9). 101131–101131. 12 indexed citations

Reverter, Enric, et al.. (2023). Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns. Seminars in Liver Disease. 43(2). 206–217. 1 indexed citations

Ramos, Natàlia, Alicia Senín, Mercedes Gironella, et al.. (2023). Role of light chain clearance in the recovery of renal function in multiple myeloma: another point of view. Clinical Kidney Journal. 16(6). 1014–1021. 6 indexed citations

Fundora, Yiliam, et al.. (2023). An infrequent cause of spontaneous liver rupture. Journal of Hepatology. 78(5). e160–e161. 1 indexed citations

10.

Toapanta, David, et al.. (2023). Exponential increase of paracetamol liver injury over the last decade in a Spanish referral center. Journal of Hepatology. 78. S135–S135.

11.

Molina‐Andújar, Alícia, Gastón Piñeiro, Enric Reverter, et al.. (2022). Management of acute renal replacement therapy in critically ill cirrhotic patients. Clinical Kidney Journal. 15(6). 1060–1070. 14 indexed citations

12.

Rubio-García, Elisa, Andrea Vergara, Fátima Aziz, et al.. (2022). Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients. Clinical Microbiology and Infection. 28(7). 975–982. 19 indexed citations

13.

Castro, Pedro, Joan R. Badia, David Toapanta, et al.. (2022). Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Medicina Intensiva (English Edition). 47(1). 1–8. 1 indexed citations

14.

Juanola, Adrià, Cristina Solé, David Toapanta, Pere Ginès, & Elsa Solà. (2021). Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis. Clinics in Liver Disease. 25(2). 441–460. 2 indexed citations

15.

Castro, Pedro, Joan R. Badia, David Toapanta, et al.. (2021). Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Medicina Intensiva. 47(1). 1–8. 7 indexed citations

16.

Zhang, Ingrid W., Anna Curto, Cristina López‐Vicario, et al.. (2021). Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure. Journal of Hepatology. 76(1). 93–106. 66 indexed citations

17.

Barbeta, Enric, Mariana Benegas, Ana Motos, et al.. (2021). Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients With COVID-19- and Non-COVID-19-Induced Acute Respiratory Distress Syndrome. Archivos de Bronconeumología. 58(2). 183–187. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact